The Acetyl Coenzyme A Synthetase Cytoplasm pipeline drugs market research report outlays comprehensive information on the Acetyl Coenzyme A Synthetase Cytoplasm targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Acetyl Coenzyme A Synthetase Cytoplasm pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
Smarter leaders trust GlobalData
The report also covers products from therapy areas such as Oncology, Central Nervous System, and Infectious Disease which include the indications Solid Tumor, Triple-Negative Breast Cancer (TNBC), Substance (Drug) Abuse, Post-Traumatic Stress Disorder (PTSD), and Malaria. It also reviews key players involved in Acetyl Coenzyme A Synthetase Cytoplasm targeted therapeutics development with respective active and dormant or discontinued products.
The Acetyl Coenzyme A Synthetase Cytoplasm pipeline targets constitutes close to six molecules. Out of which, approximately five molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase I, Preclinical, and Discovery stages are 1, 3, and 1 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Acetyl Coenzyme A Synthetase Cytoplasm overview
Acetyl-Coenzyme A Synthetase, Cytoplasmic (ACSS2) is an enzyme that plays a crucial role in cellular metabolism, specifically in the synthesis of acetyl-Coenzyme A (acetyl-CoA). Acetyl-CoA is a central metabolite involved in various biochemical pathways, including the tricarboxylic acid (TCA) cycle, fatty acid synthesis, and histone acetylation. ACSS2 is primarily localized in the cytoplasm of cells, where it catalyzes the conversion of acetate to acetyl-CoA. This enzymatic activity allows cells to utilize acetate, a short-chain fatty acid, as a substrate for energy production and various biosynthetic processes. Beyond its role in energy metabolism, ACSS2 has been implicated in the regulation of cellular processes such as gene expression and lipid metabolism. The enzyme has been found to contribute to histone acetylation, impacting chromatin structure and gene transcription. In cancer cells and other rapidly proliferating cells, ACSS2 has been shown to play a role in supporting the increased demand for acetyl-CoA necessary for accelerated growth.
For a complete picture of Acetyl Coenzyme A Synthetase Cytoplasm’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third-party sources.
Drug profiles featured in the report undergo periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
